Joan Murphy is the senior editor in charge of IEG Policy’s US Food Policy channel, where she provides comprehensive reporting on US food regulatory issues.
For more than two decades, she has written for Food Chemical News, covering legislation on Capitol Hill that impacts the food industry and food safety and labeling regulations as they develop in government agencies.
Before joining Informa, she served as a reporter for a public health association newspaper where she wrote on a wide variety of health issues. Before that, she reported on environmental policy issues for Washington, D.C.-based newsletters.
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Joan Murphy
The Senate Appropriations subcommittee approved a FY 2019 spending bill for USDA/FDA on May 22 that rejected much of the cuts proposed by the Trump administration and included a $15 million increase for FDA’s food safety program.
Rep. Rosa DeLauro (D-Conn.) has again asked FDA to clarify its handling of the investigation into a Salmonella outbreak linked to Rose Acre Farms shell eggs and the recall of more than 200 million eggs.
Mexico must honor its existing trade commitments and reject the EU’s trade proposal that will harm American cheese exporters, said a bipartisan group of senators, who wrote the U.S. Trade Representative (USTR) as the U.S., Mexico and Canada wrap up negotiations on the North American Free Trade Agreement (NAFTA).
Ocean Spray’s petition for a qualified health claim on the role of cranberry juice in preventing urinary tract infections (UTI) is not impressing the Center for Science in the Public Interest (CSPI).
Ocean Spray’s petition for a qualified health claim on the role of cranberry juice in preventing urinary tract infections (UTI) is not going down well with the Center for Science in the Public Interest (CSPI).
FDA plans new rules to amend food additive regulations, bottled water and crab meat standards, but is withdrawing rules to label imported food refused entry into the United States and to spell out FDA’s authority when suspending facility registrations.